BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
111.07
+1.04 (0.95%)
At close: Aug 5, 2025, 4:00 PM
109.33
-1.74 (-1.57%)
After-hours: Aug 5, 2025, 7:27 PM EDT
Redfin Market Cap
BioNTech SE has a market cap or net worth of $26.70 billion as of August 5, 2025. Its market cap has increased by 29.47% in one year.
Market Cap
26.70B
Enterprise Value
10.53B
1-Year Change
29.47%
Ranking
Category
Stock Price
$111.07
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $26.70B, an increase of 791.53%. That is a compound annual growth rate of 45.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 26.70B | -2.26% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |